Table 1

Microsatellite alteration of plasma and tumor DNA and clinical data concerning breast cancer patients

Patient no.Age (yr)TypeaGradeNodepTNMDM1D17S1325
TPATPA
155IDC10/20pT1cNoMo
246IDC30/16pT2NoMo
381IDC329/29pT2N2MoLL
455IDC21/10pT2N1biMo
576IDC34/15pT2N1bivMo
679IDC11/17pT2N1biMoLLLSS
768DCIS3pTisNxMoL
873IDC20/26pT4NoMoSS
972ILC20/6pT1cNoMoL
1066ILC20/14pT2NoMo
1181IDC21/14pT2N1biiiMo
1254ILC+DCIS2pT3N1biiMo
1368IDC29/22pT2N1biiiMo
1455IDC12/31pT1bN1biiiMo
1577DCIS3
1663IDC21/11pT2N1aMo
1766IDC20/25pT2NoMoL
1863ILC20/11pT2NoMo
1964IDC22/12pT2N1biiiMo
2072IDC20/14pT1sNoMoLL
2131BD
2278BD
2328BD
2443BD
2562BD
2661BD
2772BD
  • a IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; DCIS, ductal carcinoma in situ; BD, benign disease; T, tumor DNA; P, plasma DNA; A, adjacent tissue DNA; L, LOH; S, shift (appearance of new bands); −, absence of these findings.